| Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor TJN Hiltermann, MM Pore, A van den Berg, W Timens, HM Boezen, ... Annals of oncology 23 (11), 2937-2942, 2012 | 272 | 2012 |
| Targeting apoptosis pathways in lung cancer MM Pore, TJN Hiltermann, FAE Kruyt Cancer letters 332 (2), 359-368, 2013 | 114 | 2013 |
| Multiplex protein detection on circulating tumor cells from liquid biopsies using imaging mass cytometry E Gerdtsson, M Pore, JA Thiele, AS Gerdtsson, PD Malihi, R Nevarez, ... Convergent science physical oncology 4 (1), 015002, 2018 | 70 | 2018 |
| Cancer stem cells, epithelial to mesenchymal markers, and circulating tumor cells in small cell lung cancer M Pore, C Meijer, GH de Bock, W Boersma-van Ek, LWMM Terstappen, ... Clinical lung cancer 17 (6), 535-542, 2016 | 54 | 2016 |
| Serum-induced differentiation of glioblastoma neurospheres leads to enhanced migration/invasion capacity that is associated with increased MMP9 JV Joseph, IAM Roosmalen, E Busschers, T Tomar, S Conroy, ... PLoS One 10 (12), e0145393, 2015 | 49 | 2015 |
| Multiplexed probing of proteolytic enzymes using mass cytometry-compatible activity-based probes M Poreba, KM Groborz, W Rut, M Pore, SJ Snipas, M Vizovisek, B Turk, ... Journal of the American Chemical Society 142 (39), 16704-16715, 2020 | 36 | 2020 |
| Identification of epithelial and mesenchymal circulating tumor cells in clonal lineage of an aggressive prostate cancer case S Chai, C Ruiz-Velasco, A Naghdloo, M Pore, M Singh, N Matsumoto, ... NPJ Precision Oncology 6 (1), 41, 2022 | 12 | 2022 |
| Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density V Somasundaram, LA Ridnour, RY Cheng, AJ Walke, N Kedei, ... Redox Biology 58, 102529, 2022 | 11 | 2022 |
| A unique small cell lung carcinoma disease progression model shows progressive accumulation of cancer stem cell properties and CD44 as a potential diagnostic marker WS Heng, M Pore, C Meijer, TJN Hiltermann, SC Cheah, R Gosens, ... Lung Cancer 154, 13-22, 2021 | 11 | 2021 |
| Multiplex protein detection on circulating tumor cells from liquid biopsies using imaging mass cytometry. Converg Sci Phys Oncol. 2018; 4 E Gerdtsson, M Pore, JA Thiele, AS Gerdtsson, PD Malihi, R Nevarez, ... | 8 | |
| Interferon-gamma is quintessential for NOS2 and COX2 expression in ER- breast tumors that lead to poor outcome RYS Cheng, LA Ridnour, AL Wink, AL Gonzalez, EL Femino, H Rittscher, ... Cell Death & Disease 14 (5), 319, 2023 | 7 | 2023 |
| Biofunctionalized capillary flow channel platform integrated with 3D nanostructured matrix to capture circulating tumor cells SS Banerjee, GV Khutale, V Khobragade, NR Kale, M Pore, GP Chate, ... Advanced Materials Interfaces 4 (4), 1600934, 2017 | 7 | 2017 |
| TGF beta-mediated epithelial to mesenchymal transition in non small cell lung cancer: Effects on stemness, invasiveness and chemotherapy sensitivity MM Pore, L Buikema, TJN Hiltermann, FAE Kruyt Cancer Research 72 (8_Supplement), 2402-2402, 2012 | 4 | 2012 |
| Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics L Welter, S Zheng, SM Setayesh, M Morikado, A Agrawal, R Nevarez, ... Cancers 15 (15), 3949, 2023 | 1 | 2023 |
| Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumors LA Ridnour, RYS Cheng, N Kedei, V Somasundaram, DD Bhattacharyya, ... JCI insight 9 (12), 2024 | | 2024 |
| Spatial analysis of NOS2 and COX2 interaction with T-effector cells reveals immunosuppressive landscapes associated with poor outcome in ER− breast cancer patients LA Ridnour, RYS Cheng, WF Heinz, M Pore, AL Gonzalez, EL Femino, ... bioRxiv, 2023 | | 2023 |
| NOS2 and COX2 Provide Key Spatial Targets that Determine Outcome in ER− Breast Cancer LA Ridnour, WF Heinz, RYS Cheng, AL Wink, N Kedei, M Pore, F Imtiaz, ... bioRxiv, 2023 | | 2023 |
| Interferon-gamma induces NOS2 and COX2 in ER-breast cancer that drives increase metastatic potential YSR Cheng, L Ridnour, A Walke, N Kedei, A Wink, E Edmonston, ... Cancer Research 83 (7_Supplement), 2863-2863, 2023 | | 2023 |
| Multiplex proteomics profiling with the imaging mass cytometry (IMC) identifies immune cell phenotypes associated with high NOS2/COX2 expression in ER-negative and TNBC patients M Pore, L Ridnour, P Mallory, A Cardamone, S Lockett, W Bocik, D Wink Cancer Research 83 (7_Supplement), 3588-3588, 2023 | | 2023 |
| NOS2 and COX2 Blockade Limits TNBC Disease Progression and Alters CD8+ T Cell Spatial Orientation and Density V Somasundaram, LA Ridnour, RYS Cheng, AJ Walke, N Kedei, ... bioRxiv, 2022.06. 03.494733, 2022 | | 2022 |
Frank A. KruytProfessor of Experimental Oncology在 umcg.nl 的电子邮件经过验证
